Patents/Assignees

Proqr Therapeutics II B.V.

11 patents in portfolio

US12545911utility2026
Single-stranded Rna-editing Oligonucleotides
0 cites
US12398393utility2025
Rna-editing Oligonucleotides for the Treatment of Usher Syndrome
0 cites
US12275937utility2025
Stereospecific Linkages in RNA Editing Oligonucleotides
0 cites
US12203072utility2025
Chemically Modified Single-stranded Rna-editing Oligonucleotides
0 cites
US12180471utility2024
Antisense Oligonucleotides for the Treatment of Stargardt Disease
0 cites
US12018257utility2024
Single-stranded Rna-editing Oligonucleotides
0 cites
US11920132utility2024
Oligonucleotide Therapy for Leber Congenital Amaurosis
0 cites
US11866702utility2024
Nucleic Acid Molecules for Pseudouridylation
0 cites
US11851656utility2023
Chemically Modified Single-stranded Rna-editing Oligonucleotides
0 cites
US11781134utility2023
Targeted RNA Editing
0 cites
US11649454utility2023
Single-stranded Rna-editing Oligonucleotides
0 cites